A Diagnosis ("If Winter Comes" No. 2)

Probably the most horrible day in my whole life. I left the hospital early morning to go home and get the kids ready for school and come back to the hospital. 

A few minutes after arriving Dr. Sigefoos walks in and says "so we need to discuss what to do next as of your treatment." Adrian tells him that he hasn't told us and Dr. S asks if he wants him to do it. 

He explains that AJ has something called hemophagocytic syndrome. A disease that is eating up blood cells good and bad and basically not recognizing his organs as his own. I found out later that the cure rate for this disease is about 20% (!!!) I think there was a reason for them not to share that with me right away. 

Dr S, was very upfront with us and made himself available to us afterwards. He said that AJ would get a bone marrow transplant. It would be a risk in that but he should be fine since he is young and strong. He also said that he could die from this disease.... my world fell apart....

Later on in the evening when I went back to the hospital, Adrian has spoken to Dr. Beth Helerstedt and she had sent his lab works to Houston - MD Anderson Clinic, they suggested that he didn't have hemophagocytic syndrome (Misdiagnosis #4), he had Anaplastic Large Cell Lymphoma with hystiocytes. That is a much better diagnosis that can be cures with chemo and he just might need a transplant.

So that is the better one of the two bad ones and they will reconfirm tomorrow.

"If Winter Comes," A blog about anaplastic large cell lymphoma"

This blog follows the journey undertaken by my husband, by me, and by our family as my husband battles a disease we never saw coming: He was diagnosed with a rare subtype of T-cell non-Hodgkin's lymphoma known as Anaplastic Large Cell Lymphoma (ALK+) at the age of 32.

Photo by John Nyboer

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap